The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity
Open accessAbstract
Irisin is a cleaved and secreted fragment of fibronectin type III domain containing 5 (FNDC5), and contributes to the beneficial effects of exercise on metabolism. Here we report the therapeutical effects of FNDC5/irisin on metabolic derangements and insulin resistance in obesity, and show the lipolysis effect of irisin and its signal molecular mechanism. In obese mice, lentivirus mediated-FNDC5 overexpression enhanced energy expenditure, lipolysis and insulin sensitivity, and reduced hyperlipidemia, hyperglycemia, hyperinsulinism, blood pressure and norepinephrine levels; it increased hormone-sensitive lipase (HSL) expression and phosphorylation, and reduced perilipin level and adipocyte diameter in adipose tissues. Subcutaneous perfusion of irisin reduced hyperlipidemia and hyperglycemia, and improved insulin resistance. Either FNDC5 overexpression or irisin perfusion only induced a tendency toward a slight decrease in body weight in obese mice. In 3T3-L1 adipocytes, irisin enhanced basal lipolysis rather than isoproterenol-induced lipolysis, which were prevented by inhibition of adenylate cyclase or PKA; irisin increased the HSL and perilipin phosphorylation; it increased PKA activity, and cAMP and HSL mRNA levels, but reduced perilipin expression. These results indicate that FNDC5/irisin ameliorates glucose/lipid metabolic derangements and insulin resistance in obese mice, and enhances lipolysis via cAMP-PKA-HSL/perilipin pathway. FNDC5 or irisin can be taken as an effective therapeutic strategy for metabolic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Irisin was described to stimulate lipolysis via HSL and to inhibit lipid accumulation in adipocytes [58,64].”
In the citing paper
“For instance, irisin [58], IL-15 [89], and IL-6 [75] have shown to directly induce lipolysis in adipocytes (2a)”
Citations
Cites
1 retracted
An, Z., Wang, H., Song, P., Zhang, M., Geng, X., & Zou, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703701200 · Cited by 98
RetractedA PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Brown and beige fat: Development, function and therapeutic potential
Harms, M., & Seale, P. (2013) · Nature Medicine · doi:10.1038/nm.3361 · Cited by 2,328
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040
Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans
Lee, P., Linderman, J. D., Smith, S., Brychta, R. J., Wang, J., Idelson, C., Perron, R. M., Werner, C. D., Phan, G. Q., Kammula, U. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.017 · Cited by 802
Cypess, A. M., White, A. P., Vernochet, C., Schulz, T. J., Xue, R., Sass, C. A., Huang, T. L., Roberts‐Toler, C., Weiner, L. S., Sze, C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3112 · Cited by 683
FNDC5/irisin is not only a myokine but also an adipokine
Roca-Rivada, A., Castelao, C., Senin, L. L., Landrove, M. O., Baltar, J., Crujeiras, A. B., Seoane, L. M., Casanueva, F. F., & Pardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060563 · Cited by 612
Metabolic Obesity: The Paradox Between Visceral and Subcutaneous Fat
Publisher, B. S. P. B. S. (2006) · Current Diabetes Reviews · doi:10.2174/1573399810602040367 · Cited by 580
Research works printed but not linked: 1
- Muller, 2010, Is there evidence for a set point that regulates human body weight?, F1000, Med. Rep., 2, 59
Cited by
Sorted by citations
Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621
Cheng, L., Wang, J., Dai, H., Duan, Y., An, Y., Shi, L., Lv, Y., Li, H., Wang, C., Ma, Q., et al. (2021) · Adipocyte · doi:10.1080/21623945.2020.1870060 · Cited by 404
Bi, J., Zhang, J., Ren, Y., Du, Z., Li, Q., Wang, Y., Wei, S., Yang, L., Zhang, J., Liu, C., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.019 · Cited by 284
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
“For instance, irisin [58], IL-15 [89], and IL-6 [75] have shown to directly induce lipolysis in adipocytes (2a), while irisin exerts a dual effect by also inhibiting myostatin [44] (2b), reducing myostatin-mediated inhibition of WAT lipolysis [132].”
BackgroundPolyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018) · Endocrine · doi:10.1007/s12020-017-1476-1 · Cited by 262
Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H. R., & Gao, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873699 · Cited by 276
Progress and Challenges in the Biology of FNDC5 and Irisin
Maak, S., Norheim, F., Drevon, C. A., & Erickson, H. P. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab003 · Cited by 247
The role of exercise-induced myokines in regulating metabolism
Huh, J. Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0994-y · Cited by 242
Irisin exerts dual effects on browning and adipogenesis of human white adipocytes
Zhang, Y., Xie, C., Wang, H., Foss, R. M., Clare, M., George, E. V., Li, S., Katz, A. J., Cheng, H., Ding, Y., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00094.2016 · Cited by 197
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 213
New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
Rabiee, F., Lachinani, L., Ghaedi, S., Nasr‐Esfahani, M. H., Megraw, T. L., & Ghaedi, K. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00413-3 · Cited by 188
Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling
Tang, H. W., Yu, R., Liu, S., Huwatibieke, B., Li, Z., & Zhang, W. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.041 · Cited by 152
Liu, T., Xiong, X., Ren, X., Zhao, M., Shi, C., Wang, J., Zhou, Y., Zhang, F., Han, Y., Gao, X.-Y., et al. (2016) · Diabetes · doi:10.2337/db16-0356 · Cited by 135
Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors
Kang, X., Yang, M., Shi, Y., Xie, M., Zhu, M. P., Zheng, X., Zhang, C., Ge, Z., Bian, X., Lv, J.-T., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0251-0 · Cited by 121
Varela-Rodríguez, B. M., Pena-Bello, L., Juiz-Valiña, P., Bretal, B. V., Cordido, F., & Sangiao‐Alvarellos, S. (2016) · Scientific Reports · doi:10.1038/srep29898 · Cited by 115
Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
Ho, M.-Y., & Wang, C. (2021) · Cells · doi:10.3390/cells10082103 · Cited by 114
Shi, C.-X., Zhao, M.-X., Shu, X.-D., Xiong, X.-Q., Wang, J.-J., Gao, X.-Y., Chen, Q., Li, Y.-H., Kang, Y.-M., & Zhu, G.-Q. (2016) · Scientific Reports · doi:10.1038/srep21924 · Cited by 108
An update on the role of irisin in the regulation of endocrine and metabolic functions
Mahgoub, M., D’Souza, C. M., Darmaki, R. S. A., Baniyas, M. M. Y. H., & Adeghate, E. A. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.018 · Cited by 110
Irisin, a fascinating field in our times
Bao, J., She, Q.-Y., Hu, P., Jia, N., & Li, A. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.06.003 · Cited by 111
Is irisin the new player in exercise-induced adaptations or not? A 2017 update
Fatouros, I. G. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0674 · Cited by 95
The Role of Irisin in Alzheimer’s Disease
Kim, O. Y., & Song, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110407 · Cited by 91
The Role of Exercise, Diet, and Cytokines in Preventing Obesity and Improving Adipose Tissue
ATAKAN, M. M., Koşar, Ş. N., Güzel, Y., Tin, H. T., & Yan, X. (2021) · Nutrients · doi:10.3390/nu13051459 · Cited by 96
Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process
Zhang, H., Wu, X., Liang, J., Kirberger, M., & Chen, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101680 · Cited by 88
Więcek, M., Szymura, J., Maciejczyk, M., Kantorowicz, M., & Szyguła, Z. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01782 · Cited by 86
Carson, B. P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00097 · Cited by 86
So, W. Y., & Leung, P. S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.022 · Cited by 83
AlKhairi, I., Cherian, P., Abu-Farha, M., Madhoun, A. A., Nizam, R., Melhem, M., Jamal, M., Al-Sabah, S., Ali, H., Tuomilehto, J., et al. (2019) · Cells · doi:10.3390/cells8101283 · Cited by 82
Faienza, M. F., Brunetti, G., Sanesi, L., Colaianni, G., Celi, M., Piacente, L., D’Amato, G., Schipani, E., Colucci, S. C., & Grano, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.046 · Cited by 85
From Obesity to Hippocampal Neurodegeneration: Pathogenesis and Non-Pharmacological Interventions
Lee, T. H.-Y., & Yau, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010201 · Cited by 78
Impact of Lipotoxicity on Tissue “Cross Talk” and Metabolic Regulation
Montgomery, M. K., Nardo, W. D., & Watt, M. J. (2019) · Physiology · doi:10.1152/physiol.00037.2018 · Cited by 82
Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease
Maciorkowska, M., Musiałowska, D., & Małyszko, J. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/104551 · Cited by 74
Chemello, F., Grespi, F., Zulian, A., Cancellara, P., Hébert-Chatelain, É., Martini, P. G. V., Bean, C., Alessio, E., Buson, L., Bazzega, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.105 · Cited by 73
Zheng, S., Chen, N., Kang, X.-J., Hu, Y., & Shi, S. (2021) · Endocrine · doi:10.1007/s12020-021-02875-y · Cited by 70
A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus.
Gizaw, M., Anandakumar, P., & Tolessa, D. (2017) · Europe PMC (PubMed Central) · doi:10.3831/kpi.2017.20.029 · Cited by 68
RetractedDecreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
Tu, W., Qiu, H., Cao, J., Liu, Q., Zeng, X., & Zhao, J.-Z. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0651-2 · Cited by 69
Factors mediating exercise‐induced organ crosstalk
Sabaratnam, R., Wojtaszewski, J. F. P., & Højlund, K. (2022) · Acta Physiologica · doi:10.1111/apha.13766 · Cited by 70
Irisin Exerts Inhibitory Effect on Adipogenesis Through Regulation of Wnt Signaling
Ma, E. B., Sahar, N.-E., Jeong, M., & Huh, J. Y. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01085 · Cited by 69
Geng, Z., Fan, W., Zhou, B. R., Ye, C., Tong, Y., Zhou, Y., & Xiong, X. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1857-8 · Cited by 62
Association of Serum Irisin Concentrations with Presence and Severity of Coronary Artery Disease
Deng, W. (2016) · Medical Science Monitor · doi:10.12659/msm.897376 · Cited by 63
Fndc5 loss‐of‐function attenuates exercise‐induced browning of white adipose tissue in mice
Xiong, Y., Wu, Z., Zhang, B., Wang, C., Mao, F., Liu, X., Hu, K., Sun, X., Jin, W. L., & Kuang, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801754rr · Cited by 64
Adipose–Muscle Crosstalk in Age-Related Metabolic Disorders: The Emerging Roles of Adipo-Myokines
Fang, P., She, Y., Yu, M., Min, W., Shang, W., & Zhang, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101829 · Cited by 62
Disordered metabolism in mice lacking irisin
Luo, Y., Qiao, X., Ma, Y., Deng, H., Xu, C. C., & Xu, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-74588-7 · Cited by 60
The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Li, H., Wang, F., Mu, Y., Sun, J., Zhao, Y. C., & Tang, D. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6572342 · Cited by 67
Uncovering the Role of p38 Family Members in Adipose Tissue Physiology
Leiva, M., Matesanz, N., Pulgarín-Alfaro, M., Nikolić, I., & Sabio, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572089 · Cited by 62
Pérez-Sotelo, D., Roca-Rivada, A., de la Torre, I. B., Baltar, J., Castro, A. I., Domínguez, E., Collado, M., Casanueva, F. F., & Pardo, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16602-z · Cited by 59
FNDC5: A novel player in metabolism and metabolic syndrome.
Cao, R. Y., Zheng, H., Redfearn, D., & Yang, J. (2019) · Biochimie · doi:10.1016/j.biochi.2019.01.001 · Cited by 49
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56
“Adipocytes isolated from animals injected with irisin, or treated ex vivo, are therefore smaller and accumulate fewer lipids than do controls [53].”
BackgroundHsieh, C., Ho, M.-Y., Wen, M., Chen, C., Hsieh, M., Lin, C., Yeh, J., Tsai, M., Yang, C., Wu, V. C., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.072 · Cited by 55
Biondi, G., Marrano, N., Borrelli, A., Rella, M., Palma, G., CALDERONI, I., Siciliano, E., Lops, P., Giorgino, F., & Natalicchio, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105522 · Cited by 58
Elizondo‐Montemayor, L., González-Gil, A. M., Tamez‐Rivera, O., Toledo‐Salinas, C., Peschard-Franco, M., Rodríguez-Gutiérrez, N. A., Silva‐Platas, C., & García‐Rivas, G. (2019) · Mediators of Inflammation · doi:10.1155/2019/6737318 · Cited by 56
Serum irisin level in myocardial infarction patients with or without heart failure
El-Mottaleb, N. A. A., Galal, H. M., Maghraby, K., & Gadallah, A. I. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0736 · Cited by 52
Lee, T. H.-Y., Formolo, D. A., Kong, T., Lau, S. W.-Y., Ho, C. S.-L., Leung, R. Y. H., Hung, F. H.-Y., & Yau, S. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.06.002 · Cited by 49
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Glucocorticoid receptor positively regulates transcription of FNDC5 in the liver
Kim, H. K., Jeong, Y. J., Song, I.-S., Noh, Y. H., Seo, K. W., Kim, M., & Han, J. (2017) · Scientific Reports · doi:10.1038/srep43296 · Cited by 50
Huo, C.-J., Yu, X., Sun, Y., Li, H., Su, Q., Bai, J., Li, Y., Liu, K., Qi, J., Zhou, S., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114953 · Cited by 52
Ling, L., Chen, D., Tong, Y., Zang, Y.-H., Ren, X., Zhou, Y., Qi, X., Chen, Q., Li, Y., Kang, Y., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001654 · Cited by 46
The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis
Yano, N., Zhao, Y., & Zhao, T. C. (2021) · Endocrines · doi:10.3390/endocrines2030025 · Cited by 46
Butt, Z. D., Hackett, J. D., & Volkoff, H. (2017) · Peptides · doi:10.1016/j.peptides.2017.02.003 · Cited by 44
Mechanistic complexities of bone loss in Alzheimer’s disease: a review
Frame, G., Bretland, K. A., & Dengler-Crish, C. M. (2020) · Connective Tissue Research · doi:10.1080/03008207.2019.1624734 · Cited by 44
Zhou, B. R., Qiu, Y., Wu, N., Chen, A., Zhou, Y., Chen, Q., Kang, Y., Li, Y., & Zhu, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6384803 · Cited by 43
Kolodziejski, P. A., Pruszyńska‐Oszmałek, E., Wojciechowicz, T., Sassek, M., Leciejewska, N., Jasaszwili, M., Billert, M., Małek, E., Szczepankiewicz, D., Misiewicz-Mielnik, M., et al. (2021) · Genes · doi:10.3390/genes12050756 · Cited by 46
Pervin, S., Reddy, S. T., & Singh, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653179 · Cited by 42
Schaalan, M. F., Ramadan, B. K., & Elwahab, A. H. A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26370 · Cited by 42
Ye, C., Tong, Y., Wu, N., Wan, G.-W., Zheng, F., Chen, J., Lei, J., Zhou, H., Chen, A., Wang, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00608-x · Cited by 42
Zhang, Y.-S., He, X., Wang, K., Xue, Y., Hu, S.-H., Jin, Y.-S., Zhu, G., Rui, Y.-J., & Shi, Q. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.013 · Cited by 49
Irandoost, P., Alamdari, N. M., Saidpour, A., Shidfar, F., Roshanravan, N., Jafarabadi, M. A., Farsi, F., Hanjani, N. A., & Vafa, M. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13493 · Cited by 40
Zang, Y.-H., Chen, D., Zhou, B. R., Chen, A., Wang, J., Gao, X.-Y., Chen, Q., Li, Y., Kang, Y., & Zhu, G. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.106579 · Cited by 40
Bretland, K. A., Lin, L., Bretland, K. M., Smith, M. A., Fleming, S. M., & Crish, S. D. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12711 · Cited by 43
Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome
Adamska, A., Karczewska‐Kupczewska, M., Łebkowska, A., Milewski, R. J., Górska, M., Otziomek, E., Nikołajuk, A., Wołczyński, S., & Kowalska, I. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0249 · Cited by 38
Ye, C., Zheng, F., Xu, T., Wu, N., Tong, Y., Xiong, X., Zhou, Y., Wang, J., Chen, Q., Li, Y., et al. (2022) · Theranostics · doi:10.7150/thno.70974 · Cited by 37
Das, S., Mukhuty, A., Mullen, G. P., & Rudolph, M. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126681 · Cited by 43
Mechanism of CNS regulation by irisin, a multifunctional protein
Qi, J., Yang, L.-K., Wang, X., Wang, M., Li, X., Feng, B., Wu, Y., Liu, S., & Zhang, K. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.007 · Cited by 37
Relation of serum irisin level with metabolic and antropometric parameters in obese children
Çatlı, G., Küme, T., Tuhan, H., Anık, A., Çalan, Ö. G., Böber, E., & Abacı, A. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.019 · Cited by 34
Zheng, G., Li, H., Zhang, T., Yang, L., Yao, S., Chen, S., Zheng, M., Zhao, Q., & Tian, H. (2017) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2017.08.018 · Cited by 34
Więcek, M., Szymura, J., Sproull, J., & Szyguła, Z. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092797 · Cited by 33
Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
Li, H., Shen, J., Wu, T., Kuang, J., Liu, Q., Cheng, S., Pu, S., Chen, L., Li, R., Li, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00548 · Cited by 33
Factors Associated with White Fat Browning: New Regulators of Lipid Metabolism
Zhang, P., He, Y., Wu, S., Li, X., Lin, X., Gan, M., Chen, L., Zhao, Y., Niu, L., Zhang, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147641 · Cited by 36
Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brain
Natalicchio, A., Marrano, N., Biondi, G., Dipaola, L., Spagnuolo, R., Cignarelli, A., Perrini, S., Laviola, L., & Giorgino, F. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3238 · Cited by 31
Wang, P., Ma, H.-H., Hou, X., Song, L., Song, X.-L., & Zhang, J.-F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.038 · Cited by 31
Osella, A. R., Colaianni, G., Correale, M., Pesole, P. L., Bruno, I., Buongiorno, C., Deflorio, V., Leone, C. M., Colucci, S. C., Grano, M., et al. (2018) · Nutrients · doi:10.3390/nu10070844 · Cited by 31
Role of Irisin in Endocrine and Metabolic Disorders—Possible New Therapeutic Agent?
Leuștean, L., Preda, C., Teodoriu, L. C., Mihalache, L., Arhire, L. I., & Ungureanu, M.-C. (2021) · Applied Sciences · doi:10.3390/app11125579 · Cited by 33
Irisin and Energy Metabolism and the Role of Irisin on Metabolic Syndrome
Aladag, T., Moğulkoç, R., & Baltacı, A. K. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230411105506 · Cited by 30
Guo, Q., Wei, X., Hu, H., Yang, D., Zhang, B., Fan, X., Liu, J., He, H., Oh, Y., Wu, Q., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.077 · Cited by 30
Irisin and Chemerin Levels in Patients with Type 2 Diabetes Mellitus
Balaban, Y. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.442 · Cited by 30
Zhang, X., Hu, C., Wu, H., Ma, Z., & Tang, Q. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00557-5 · Cited by 30
Yang, M., Dai, H., Luo, L., & Yang, J. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00821-1 · Cited by 30
Exercise-regulated lipolysis: Its role and mechanism in health and diseases
Zhu, J., & Guo, L. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.11.031 · Cited by 33
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice
Luo, H.-Y., Mu, W.-J., Chen, M., Zhu, J., Li, Y., Li, S., Yan, L.-J., Li, R.-Y., Yin, M.-T., Li, X., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155916 · Cited by 28
Mechanisms of altered bone remodeling in children with type 1 diabetes
Brunetti, G., D’Amato, G., Santis, S. D., Grano, M., & Faienza, M. F. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.997 · Cited by 27
Özcan, S., Ülker, N., Bulmuş, Ö., Yardımcı, A., Özcan, M., & Canpolat, S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1722706 · Cited by 27
Acierno, C., Barletta, F., Caturano, A., Nevola, R., Sasso, F. C., Adinolfi, L. E., & Rinaldi, L. (2025) · Nutrients · doi:10.3390/nu17132229 · Cited by 33
The Acute Effects of Swimming Exercise on PGC-1α-FNDC5/Irisin-UCP1 Expression in Male C57BL/6J Mice
Cho, E., Jeong, D. Y., Kim, J. G., & Lee, S. (2021) · Metabolites · doi:10.3390/metabo11020111 · Cited by 25
Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus
Hekım, M. G., Keleştemur, M. M., Bulmuş, F. G., Bılgın, B., Bulut, F., Gökdere, E., Ozdede, M. R., Keleştimur, H., Canpolat, S., & Özcan, M. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1894178 · Cited by 27
The Potential of Irisin as a Therapeutic for Diabetes
Leung, P. S. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0035 · Cited by 25
Exercise and Metabolic Health: The Emerging Roles of Novel Exerkines
Yazgan, B., Türkel, İ., Özerkliğ, B., ATAKAN, M. M., Aktitiz, S., & Koşar, Ş. N. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220629163524 · Cited by 25
Irisin Regulates the Functions of Hepatic Stellate Cells
Dong, H. N., Park, S. Y., Le, C. T., Choi, D.-H., & Cho, E.-H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.658 · Cited by 24
Jiang, S., Piao, L., Ma, E. B., Ha, H., & Huh, J. Y. (2021) · Biomolecules · doi:10.3390/biom11020322 · Cited by 25
Kuppusamy, P., Soundharrajan, I., Hwang, I. H., Kim, D., & Choi, K. C. (2021) · Molecules · doi:10.3390/molecules26071984 · Cited by 23
Sun, H., Cao, L., Zhu, M., Wu, Z., Shen, C., Nie, X.-W., & Bian, J. (2020) · Theranostics · doi:10.7150/thno.46053 · Cited by 22
Zhou, B. R., Wu, L., Zheng, F., Wu, N., Chen, A., Zhou, H., Chen, J., Chen, Q., Li, Y., Kang, Y., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9081009 · Cited by 22
Metadata
- Authors
- Xiong, X.-Q., Chen, D., Sun, H.-J., Ding, L., Wang, J.-J., Chen, Q., Li, Y.-H., Zhou, Y.-B., Han, Y., Zhang, F., Gao, X.-Y., Kang, Y.-M., & Zhu, G.-Q.
- Affiliations
- Nanjing Medical University (CN)
- Xi'an Jiaotong University (CN)
- Corresponding author
- Zhu, Guo-Qing
- ORCID
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 1852
- Issue
- 9
- Pages
- 1867-1875
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1931609017
- Cited by
- 242
- References
- 37
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 23 · 2023: 13 · 2022: 43 · 2021: 38 · 2020: 23 · 2019: 23 · 2018: 18 · 2017: 13 · 2016: 15 · 2015: 1
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31171095, 31271213, 91439120)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- FNDC5, irisin, obesity, insulin resistance, lipolysis, hyperlipidemia, hyperglycemia, hormone-sensitive lipase, perilipin, cAMP/PKA signaling, energy expenditure, adipocytes, exercise metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review